HIV INFECTION
Clinical trials for HIV INFECTION explained in plain language.
Never miss a new study
Get alerted when new HIV INFECTION trials appear
Sign up with your email to follow new studies for HIV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could one shot be enough? study tests simpler HPV vaccine for kids with HIV
⭐️ VACCINE ⭐️ OngoingThis study aims to find the simplest and most effective number of HPV vaccine doses for children and adolescents living with HIV. It compares three different dosing schedules, including testing if a single dose provides good protection. The goal is to make vaccination easier and …
Matched conditions: HIV INFECTION
Phase: PHASE4 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 20, 2026 14:47 UTC
-
Scientists test 'Double-Edged' gene therapy to fight HIV and cancer at once
Disease control OngoingThis early-stage study is testing a two-part treatment for people with AIDS-related lymphoma. First, patients receive standard chemotherapy to fight the cancer. Then, they receive an infusion of their own blood stem cells that have been genetically modified in a lab to resist HIV…
Matched conditions: HIV INFECTION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Gentler surgery tested to fight anal cancer in HIV patients
Disease control OngoingThis study is testing whether a minor surgical procedure can effectively treat very early-stage anal cancer in people living with HIV. Researchers want to see if removing just the small cancerous area is a safer option with fewer side effects than standard treatments like radiati…
Matched conditions: HIV INFECTION
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test 'Gene Armor' to fight HIV and cancer
Disease control OngoingThis early-stage study is testing a new gene therapy for people with HIV who also have a type of cancer called non-Hodgkin lymphoma. Doctors collect a patient's own blood stem cells, modify them in a lab to carry genes that may fight HIV, and then return them to the patient after…
Matched conditions: HIV INFECTION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
HIV drug safety check: Two-Year Follow-Up for 641 patients
Disease control OngoingThis study is checking the long-term safety and effectiveness of a daily HIV pill (doravirine/islatravir) in people who are already taking it from earlier research. It follows 641 adults with HIV for 96 weeks to monitor side effects and see how well the virus remains controlled. …
Matched conditions: HIV INFECTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New combo therapy trial offers hope for HIV patients with advanced cancers
Disease control OngoingThis is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…
Matched conditions: HIV INFECTION
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New study aims to catch cancer earlier for people with HIV
Diagnosis OngoingThis study is testing different combinations of screening tests to find the best way to detect early, pre-cancerous changes in the cervix and anus of people living with HIV. People with HIV are at higher risk for cancers caused by HPV. The research involves over 1,500 adults in M…
Matched conditions: HIV INFECTION
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Apr 02, 2026 14:58 UTC
-
Scientists test new antibody shot that could block HIV
Prevention OngoingThis early-stage study is testing the safety of a new antibody injection called CAP256J3LS in healthy adults. The antibody is designed to target and neutralize HIV, potentially preventing infection. Researchers are giving the antibody as either a single shot or three shots over s…
Matched conditions: HIV INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Mar 23, 2026 15:18 UTC